Medifast (NYSE:MED)

GeoProfile
Overview
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders

Sunday, May 10, 2009

Potential Valuation Scenarios

Valuation Scenarios

Data Inputs:

Fiscal Year Ends in December

Date	5/8/09
Price	$6.65
12 Months Trailing EPS	$0.45
Published 2009 Analyst EPS Estimates	$0.58
Future EPS Growth Rate Based on Estimates	65%
Trailing P/E Ratio	14.78
PEG Ratio (P/E divided by growth rate)	0.23

Short-Term Valuation Scenarios

Date	5/8/09
Price Based on P/E of 25 on Four Quarters Trailing EPS	$11.25
Price Based on P/E of 20 on Four Quarters Trailing EPS	$9.00
Price Based on P/E of 15 on 2009 Analyst EPS Estimates	$8.70

Long-Term (12 Months Forward) Valuation Scenarios

Date	5/8/09
Price Based on P/E of 25 on 2009 Analyst EPS Estimates	$14.50
Price Based on P/E of 20 on 2009 Analyst EPS Estimates	$11.60

Peg Ratio Analysis - Common rule of thumb that PEG ratio should be less than 1.0

PEG Ratio Less than 1?

YES

These scenarios are not investment advice, but are scenarios based on some commonly used investment guidelines. They are provided to aid investors in making their own investment decisions.